TNFAIP3 and rheumatoid arthritis: Therefore, thanks to this study, it can be stated that myeloid cell-specific A20-/- mice can be used as a pre-clinical models for the validation of therapies for RA that have the aim of modifying inflammasome or IL-1 signaling [150].